OrbiMed portfolio
177 tracked investments, 137 on the map, $9.6B raised across the mapped portfolio.
Intellia Therapeutics
Harmony BiosciencesDebt Financing
Janux TherapeuticsSeries B
Arcutis Biotherapeutics
Mineralys TherapeuticsPost-IPO Equity
InvivydSeries C
Avalo TherapeuticsPost-IPO Equity
Aspen NeuroscienceSeries C
Keros TherapeuticsSeries C
Alentis Therapeutics
DELFI Diagnostics
Mirador Therapeutics
Cerapedics
Trisalus Life SciencesPost-IPO Debt
Cytek BiosciencesSeries D
Noctrix Health
AdimabSeries DKoya MedicalSeries C
Verastem OncologyPost-IPO Equity- SSynthorxSeries C
LEXICON PHARMACEUTICALSPost-IPO Equity
NeuroPaceVenture- TTTarganta TherapeuticsSeries C
enGenePost-IPO Equity
Owlet Baby CarePost-IPO Equity
Perfuse TherapeuticsSeries A
Sidewinder TherapeuticsSeries B
Terremoto BiosciencesSeries C
BlossomHill TherapeuticsSeries B
Terns PharmaceuticalsSeries C
Avenzo TherapeuticsSeries B
RayzeBioSeries C
vVardisVenture Round
BiobeatSeries B
Fore BiotherapeuticsSeries D
SpectronRxPrivate Equity Round
Compass TherapeuticsPost-IPO Equity
Q32 BioPost-IPO Equity
MinervaxVenture Round
KapivaSeries C
ReCode TherapeuticsSeries B
argenxSeries B
ApollomicsSeries B
Pee SafeSeries C
Repare TherapeuticsSeries B
Zai LabSeries C
Edgewise TherapeuticsPost-IPO Equity
Leal TherapeuticsSeries A
InsmedPost-IPO Debt
ProLynxSeries A
Stratus TherapeuticsSeries A
Binx HealthSeries E
QuantX BiosciencesSeries A
Myriad GeneticsPost-IPO Debt
Congruence TherapeuticsVenture Round
Sionna TherapeuticsSeries C
Ascendis PharmaSeries D
Iovance BiotherapeuticsPost-IPO Equity
Avita MedicalPost-IPO Debt
ETHRISSeries A
AdelaSeries A
Helicore BiopharmaSeries A
Alpheus MedicalSeries B
Vanqua BioSeries B
YarrowVenture Round
ValnevaPost-IPO Debt
ACELYRINSeries C
EmendoBio, Inc.Series B
C4 TherapeuticsPost-IPO Equity
sikka.aiSeries C
LifeCell InternationalVenture Round
Pionyr ImmunotherapeuticsSeries B
Fate TherapeuticsPost-IPO Equity
Adaptive BiotechnologiesPost-IPO Debt
NetmedsSeries A
Scout BioSeries B
Pinnacle MedicinesSeries A
InvitaeSeries F
Theseus PharmaceuticalsSeries B
ImmPACT BioSeries B
DIH TechnologyPost-IPO Equity
Cullinan TherapeuticsPost-IPO Equity
Promentis PharmaceuticalsSeries C
MabPlex InternationalSeries B
Suraksha DiagnosticsVenture Round
89bioSeries A
BIOMxPost-IPO Equity
VIVUSPost-IPO Equity
Cyrus BiotechnologySeries B
Passage BioSeries B
Harvest Integrated Research OrganizationSeries A
RedHill BiopharmaPost-IPO Equity
Fusion PharmaceuticalsSeries B
Corvus PharmaceuticalsPost-IPO Equity
Kerala Institute of Medical SciencesPrivate Equity Round
Alpine Immune SciencesPost-IPO Equity
AvitideSeries E
Arcatron MobilityVenture Round
TELA BioVenture Round
Sublimity TherapeuticsVenture Round
Also in the portfolio
- Caris Life Sciences
- BioAge Labs
- Apogee Therapeutics
- Nautilus Biotechnology
- Carrot Fertility
- Nuvation Bio
- TigerConnect
- Crossover Health
- Natera
- CHARM Therapeutics
- Treeline Biosciences
- Tyra Biosciences
- Verdiva Bio
- Averna Therapeutics
- TandemAI
- Stairway Medical
- Evozyne
- Evox Therapeutics
- Health Catalyst
- Prelude Therapeutics
- EDDA Technology
- Clover Biopharmaceuticals
- Magenta Medical
- Nucleix
- Inspire Medical Systems
- TransMedics
- Aer Therapeutics
- Shattuck Labs
- Alector
- Ikena Oncology
- Affimed
- Acutus Medical
- Aduro BioTech
- Imara
- Arsanis
- Practice Fusion
- Roka Bioscience
- Cerexa Inc.